Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00154388
Status:
COMPLETED
Last Update Posted:
2016-11-18
First Post:
2005-09-09
Brief Title:
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-02
Start Date Type:
None
Primary Completion Date:
2007-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-09
First Submit QC Date:
September 9 2005
Study First Post Date:
2005-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-16
Last Update Post Date:
2016-11-18
Last Update Post Date Type:
ESTIMATED